# Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

> **NCT00003945** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 400 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00003945
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2013-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003945, "Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*